Skip to main content
Flora Growth Corp. logo

Flora Growth Corp. — Investor Relations & Filings

Ticker · FLGC ISIN · CA3397641026 LEI · 98450048403E01089069 US Manufacturing
Open in API
Filings indexed 310 across all filing types
Latest filing 2026-05-06 Remuneration Information
Country CA Canada
Listing US FLGC

About Flora Growth Corp.

https://www.floragrowth.com/

Flora Growth Corp. is an international pharmaceutical distributor and a digital assets treasury company. The company's primary activities include sourcing, importing, and distributing prescription and over-the-counter pharmaceuticals through its established network. The company also has a history in the cultivation and processing of cannabis for medicinal-grade flower and derivative products, managing a portfolio of consumer brands in the wellness sector.

Recent filings

Filing Released Lang Actions
8-K - ZeroStack Corp. (0001790169) (Filer)
Remuneration Information Classification · 82% confidence The document is a Form 8-K “Current Report” filed under Item 5.02 “Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.” It describes stock option grants (i.e., compensation arrangements) for the CEO, CFO, and Executive Chairman. This is not an annual or interim report, earnings release, proxy statement, or a simple publication notice. Instead, it details executive compensation arrangements, matching the definition of Remuneration Information (Code: DEF 14A).
2026-05-06 English
8-K - ZeroStack Corp. (0001790169) (Filer)
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. It details material definitive agreements entered into, including securities contribution agreements, stockholders' agreement, share exchange agreement, and note settlement agreement. It also includes information about unregistered sales of equity securities. The document is not an annual or quarterly report, nor is it an earnings release or proxy statement. It is a regulatory filing reporting material events and agreements. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length and content confirm it is a full filing, not just an announcement or certification.
2026-03-31 English
10-K - FLORA GROWTH CORP. (0001790169) (Filer)
Annual Report FY 2025
2026-02-27 English
8-K Filing
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes a corporate name change, ticker symbol change, and related amendments to articles of incorporation. It does not contain financial statements or detailed financial analysis. The document length is 4004 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. The nature of the content is a regulatory filing announcing corporate changes, not an annual or quarterly report, audit report, or earnings release. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2026-01-29 English
424B5 Filing
Capital/Financing Update Classification · 100% confidence The document is a preliminary prospectus supplement filed pursuant to Rule 424(b)(5) related to a registration statement on Form S-3 under the Securities Act of 1933. It details an offering of common shares by Flora Growth Corp., including information about the offering, underwriting, risk factors, business overview, and use of proceeds. The document is a detailed disclosure related to capital raising and securities issuance, typical of a prospectus supplement. It is not a financial report, earnings release, management discussion, or any other report type. It is clearly a capital/financing update document related to a securities offering.
2026-01-27 English
424B3 Filing
Capital/Financing Update Classification · 95% confidence The document is titled 'Supplement No. 1 to Prospectus Supplement' and references a Sales Agreement for an at-the-market (ATM) offering of common shares. It announces the suspension of the ATM offering and termination of the continuous offering under the Prospectus Supplement and Prospectus. The document is a regulatory filing related to capital raising activities but does not itself contain financial statements or detailed financial data. It is a notice about financing activity and changes to the offering terms. Given the content and context, this fits best under 'Capital/Financing Update' (CAP). The document length is short and it is not a full prospectus or annual report, so it is not a report publication announcement or annual report. Therefore, the classification is CAP with high confidence.
2026-01-27 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.